United States · FDA National Drug Code directory
ALYFTREK
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51167-135_fe5c4f96-377c-455b-896c-4886c10d5098
- Product NDC
- 51167-135
- Form
- TABLET, FILM COATED
- Composition / generic term
- vanzacaftor, tezacaftor, and deutivacaftor
- Labeler
- Vertex Pharmaceuticals Incorporated
- Marketing category
- NDA
- Marketing start / end (source format)
- 20241220
- Source listing expiry
- 20271231
Source-listed ingredients
- VANZACAFTOR — 4 mg/1
- TEZACAFTOR — 20 mg/1
- DEUTIVACAFTOR — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 4 BLISTER PACK in 1 CARTON (51167-135-01) / 21 TABLET, FILM COATED in 1 BLISTER PACK · 51167-135-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →